Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA).
Khaleva E, Rattu A, Brightling C, Bush A, Bossios A, Bourdin A, Chung KF, Chaudhuri R, Coleman C, Dahlén SE, Djukanovic R, Deschildre A, Fleming L, Fowler SJ, Gupta A, Hamelmann E, Hashimoto S, Hedlin G, Koppelman GH, Melén E, Murray CS, Pilette C, Porsbjerg C, Pike KC, Rusconi F, Williams C, Ahrens B, Alter P, Anckers F, van den Berge M, Blumchen K, Brusselle G, Clarke GW, Cunoosamy D, Dahlén B, Dixey P, Exley A, Frey U, Gaillard EA, Giovannini-Chami L, Grigg J, Hartenstein D, Heaney LG, Karadag B, Kaul S, Kull I, Licari A, Maitland-van der Zee AH, Mahler V, Schoos AM, Nagakumar P, Negus J, Nielsen H, Paton J, Pijnenburg M, Ramiconi V, Romagosa Vilarnau S, Principe S, Rutjes N, Saglani S, Seddon P, Singer F, Staudinger H, Turner S, Vijverberg S, Winders T, Yasinska V, Roberts G; COMSA Working Group in the 3TR Consortium. Khaleva E, et al. Among authors: dahlen b. Eur Respir J. 2023 Apr 3;61(4):2200606. doi: 10.1183/13993003.00606-2022. Print 2023 Apr. Eur Respir J. 2023. PMID: 36229046 Free PMC article. Review.
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
Dahlén SE, Malmström K, Nizankowska E, Dahlén B, Kuna P, Kowalski M, Lumry WR, Picado C, Stevenson DD, Bousquet J, Pauwels R, Holgate ST, Shahane A, Zhang J, Reiss TF, Szczeklik A. Dahlén SE, et al. Among authors: dahlen b. Am J Respir Crit Care Med. 2002 Jan 1;165(1):9-14. doi: 10.1164/ajrccm.165.1.2010080. Am J Respir Crit Care Med. 2002. PMID: 11779723 Clinical Trial.
Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib.
Gyllfors P, Bochenek G, Overholt J, Drupka D, Kumlin M, Sheller J, Nizankowska E, Isakson PC, Mejza F, Lefkowith JB, Dahlén SE, Szczeklik A, Murray JJ, Dahlén B. Gyllfors P, et al. Among authors: dahlen b, dahlen se. J Allergy Clin Immunol. 2003 May;111(5):1116-21. doi: 10.1067/mai.2003.1450. J Allergy Clin Immunol. 2003. PMID: 12743579 Clinical Trial.
[TNF-blockade--new strategy in difficult-to-treat asthma].
Dahlén SE, Millinger E, Skedinger M, Zetterström O, Dahlén B. Dahlén SE, et al. Among authors: dahlen b. Lakartidningen. 2008 Jun 25-Jul 1;105(26-27):1946-8. Lakartidningen. 2008. PMID: 18681378 Swedish. No abstract available.
Problematic severe asthma: a proposed approach to identifying children who are severely resistant to therapy.
Konradsen JR, Nordlund B, Lidegran M, Pedroletti C, Grönlund H, van Hage M, Dahlen B, Hedlin G; Swedish Network of Pediatric Allergists, Severe Asthma Network. Konradsen JR, et al. Among authors: dahlen b. Pediatr Allergy Immunol. 2011 Feb;22(1 Pt 1):9-18. doi: 10.1111/j.1399-3038.2010.01098.x. Epub 2010 Sep 30. Pediatr Allergy Immunol. 2011. PMID: 20880352
Asthma treatment guidelines meet the real world.
Dahlén SE, Dahlén B, Drazen JM. Dahlén SE, et al. Among authors: dahlen b. N Engl J Med. 2011 May 5;364(18):1769-70. doi: 10.1056/NEJMe1100937. N Engl J Med. 2011. PMID: 21542748 No abstract available.
177 results